We care, for the better.
A place for professionals to develop innovative practice, connect with their peers and put families first.
Support Adfam and receive our policy briefings.
You have successfully signed up to receive our policy briefing.
On Twitter? Get up to date information directly to your feed. Follow @AdfamUK.
Hepatitis C and Families
15 Dec 2016
Adfam has been funded by Gilead Sciences to research the impact of hepatitis C on family members of those injecting drugs. It is estimated that approximately 214,000 people in the UK are living with chronic hepatitis C, but only around half of people who inject drugs know their hepatitis C status. This is despite intravenous drug-users being one of the groups most at risk of contracting the disease.
The experiences of family members are largely undocumented; this piece of research aims to rectify this. There are two surveys:
- One for family members of people who have been diagnosed with hepatitis C
- One for family members of people who inject drugs, and are therefore at risk of contracting hepatitis C, but do not have a diagnosis
The answers you provide will be kept wholly confidential, though if you are happy to discuss your answers in more detail you can opt to leave your contact details.
The surveys are open until 8 February 2017.
If you have any questions about the research, please contact Alison Hill.